Reliant Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-28,990
Closed -$3.02M 62
2017
Q4
$3.02M Buy
28,990
+1,335
+5% +$151K 2.07% 27
2017
Q3
$4.03M Sell
27,655
-330
-1% -$44.9K 3.39% 7
2017
Q2
$3.63M Buy
27,985
+180
+0.6% +$22.1K 2.83% 13
2017
Q1
$3.46M Sell
27,805
-485
-2% -$58K 2.7% 13
2016
Q4
$3.27M Sell
28,290
-28,215
-50% -$3.14M 2.67% 15
2016
Q3
$5.74M Buy
56,505
+28,385
+101% +$3.07M 2.56% 20
2016
Q2
$2.77M Buy
28,120
+365
+1% +$37.8K 2.52% 21
2016
Q1
$2.78M Buy
+27,755
New +$2.86M 2.7% 19

Other funds holding CELG

Reliant Investment Management's CELG Position: Q1 2018 in Review

Reliant Investment Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 28,990 shares — an estimated $3.02M sold.

Reliant Investment Management first reported a position in CELG in Q1 2016 and held it in 8 quarters. The position peaked at $5.74M in Q3 2016. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Reliant Investment Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Reliant Investment Management sold 28,990 Celgene Corp shares in Q1 2018, an estimated $3.02M.
  • Reliant Investment Management first reported a position in Celgene Corp in Q1 2016 and held it in 8 quarters.
  • Reliant Investment Management's Celgene Corp position peaked at $5.74M in Q3 2016.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Reliant Investment Management's 13F filing for Q1 2018, filed 31 May 2018.